KLRK1 and neoplasm: In fact, the interaction between the NKG2D receptor of natural killer (NK) cells with cytotoxic T lymphocytes (CTLs), and UL16 binding protein 2 (ULBP2), which is an NKG2D ligand expressed in tumor cells, allows NK cells to kill the tumor cells.